Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients

American Journal of Kidney Diseases

Volumn 38, Issue 4, 2001, Pages S172-S174

  Nakanishi, Shohei ^a,b,c,d,e,f   Kazama, Junichiro J ^a,b,c,d,e,f   Shigematsu, Takashi ^a,b,c,d,e,f   Iwasaki, Yoshiko ^a,b,c,d,e,f   Cantor, Thomas L ^a,b,c,d,e,f   Kurosawa, Takeshi ^a,b,c,d,e,f   Fukagawa, Masafumi ^a,b,c,d,e,f  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO TEISHIN HOSPITAL   (Japan)

^e Scanticodies Laboratories Inc   (United States)

^f Sumiyoshi Clinic Hospital   (Japan)

Author keywords

Bone metabolic markers; Hemodialysis; Intact parathyroid hormone (PTH); Whole PTH

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; BONE METABOLISM; BONE TURNOVER; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIALYSIS; FEMALE; HEMODIALYSIS; HORMONE DETERMINATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; UREMIA;

ALKALINE PHOSPHATASE; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; BONE AND BONES; BONE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; REGRESSION ANALYSIS; RENAL DIALYSIS;

EID: 0034806085     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.27436     Document Type: Article

References (14)

1. The spectrum of bone disease in end-stage renal failure - An evolving disorder
2. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
3. Risk factors for vertebral fractures in renal osteodystrophy
4. Increased incidence of hip fracture in dialysis patients with low serum parathyroid hormone
5. Intact parathyroid hormone over-estimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia
6. Accumulation of a non-(l-84) molecular form of parathyroid (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values
7. A non-(I-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples
8. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure
9. Development of novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function
10. A novel mechanism for skeletal resistance in uremia
11. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia
12. Circulating biochemical markers of bone remodeling in uremic patients
13. The 1-84:7-84 PTH ratio for determination of bone turnover in chronically dialyzed patients
14. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis